Valuation: Kenvue Inc.

Market Cap 37.08B 32.2B 29.9B 27.58B 51.95B 3,540B 52.89B 354B 139B 1,758B 139B 136B 5,912B P/E 2026 *
20.3x
P/E 2027 * 18.1x
Enterprise Value 44.48B 38.64B 35.88B 33.09B 62.33B 4,247B 63.46B 425B 166B 2,109B 167B 163B 7,093B EV / Sales 2026 *
2.85x
EV / Sales 2027 * 2.74x
Free-Float
98.9%
Yield 2026 *
4.39%
Yield 2027 * 4.49%
1 day-0.44%
1 week+2.17%
Current month+1.05%
1 month+1.05%
3 months+10.15%
6 months+10.98%
Current year+11.94%
1 week 19.1
Extreme 19.095
20.05
1 month 18.58
Extreme 18.58
20.13
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
22.28
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
5/1/26 Fiscal year

Group President LATAM

55,637 0.0029%
3/30/26 Free

Director

1,331 0.0001%
2/13/26 Fiscal year

Chief Operating Officer

64,111 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
-2.43%+2.17%-10.93%-20.86% 37.08B
-1.46%-2.05%-5.83%-7.96% 335B
-2.03%+3.79%-4.23%+0.72% 140B
-2.02%+1.69%+6.76%+21.13% 73.3B
-0.31%-2.80%-13.79%-17.94% 51.88B
+0.89%+6.21%-9.37%-52.96% 30.71B
-0.30%+3.59%-26.31%-31.82% 20.32B
-0.31%+0.07%+14.49%+5.98% 19.7B
-3.43%+1.40%-4.02%+20.99% 19.2B
-0.16%+1.11%-12.02%+3.33% 11.49B
Average -0.74%+2.41%-6.53%-7.94% 73.93B
Weighted average by Cap. -0.65%+2.36%-5.31%-6.00%

Financials

2026 *2027 *
Net sales 15.63B 13.57B 12.6B 11.62B 21.89B 1,492B 22.29B 149B 58.42B 741B 58.68B 57.39B 2,492B 16.02B 13.92B 12.92B 11.92B 22.45B 1,530B 22.86B 153B 59.9B 760B 60.17B 58.85B 2,555B
Net income 1.84B 1.6B 1.49B 1.37B 2.58B 176B 2.63B 17.6B 6.89B 87.38B 6.92B 6.77B 294B 2.06B 1.79B 1.67B 1.54B 2.89B 197B 2.95B 19.72B 7.72B 97.9B 7.75B 7.58B 329B
Net Debt 7.41B 6.43B 5.97B 5.51B 10.38B 707B 10.57B 70.72B 27.69B 351B 27.81B 27.2B 1,181B 6.81B 5.92B 5.49B 5.07B 9.54B 650B 9.72B 65.04B 25.47B 323B 25.58B 25.02B 1,086B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-07-30 US$19.31 -2.43% 16,297,221
26-07-29 US$19.79 +0.20% 27,193,670
26-07-28 US$19.75 +1.39% 19,625,025
26-07-27 US$19.48 +1.04% 20,910,019
26-07-24 US$19.28 +2.01% 21,434,276
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.31USD
Average target price
19.83USD
Spread / Average Target
+2.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock